definiens: shall mean all ( a ) Net Sales, ( b ) license fees, sublicense fees and milestone payments paid by a third party to obtain rights to Program Vaccine(s ) or Combined Vaccine(s ), as applicable, ( c ) premiums over fair market value of any equity of a Party issued to a third party in a transaction or series of transactions in which such third party obtains rights to Program Vaccine(s ) or Combined Vaccine(s ), as applicable, and ( d ) royalties paid by a third party to obtain rights to Program Vaccine(s ) or Combined Vaccine(s ), as applicable, but excluding any such amounts received ( 1 ) as payment for the fair market value of any equity issued, ( 2 ) as payments for the supply of goods equal to the cost of goods sold, ( 3 ) as research and development funding and ( 4 ) as payment from EPIMMUNE or a third party partner of EPIMMUNE for obtaining rights to the BAVARIAN NORDIC Manufacturing Technology